Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Lilly to build $2.5 billion diabetes drug plant in Germany
By Klaus Lauer and Ludwig Burger (Reuters) - Eli Lilly will build its first plant in Germany for 2.3 billion euros ($2.5 billion) in the western town of Alzey, the U.S. pharmaceuticals maker said on F...
Nov 17, 2023
Retail investors crowd into Eli Lilly after weight-loss drug approval
By Bhanvi Satija and Amruta Khandekar (Reuters) - Retail flows into Eli Lilly spiked to a more than two-year high in November, as small investors rushed to buy the stock after the U.S. pharma major re...
Nov 17, 2023
Lilly extends tender offer to acquire Point Biopharma to Dec 1
(Reuters) - Eli Lilly said on Friday it was extending the deadline for its tender offer for Point Biopharma shares to Dec. 1, from Nov. 16 previously. In October, Lilly agreed to acquire the company i...
Nov 17, 2023
WHO voices concern over spread of disease in Gaza
GENEVA (Reuters) - The World Health Organization said on Friday it was very concerned about the spread of disease of Gaza as weeks of Israeli bombardments have caused the population to crowd in shelte...
Nov 17, 2023
Japan to buy 1.4 million doses of Daiichi Sankyo COVID vaccine
TOKYO (Reuters) - Japan's health ministry said on Friday it agreed to buy 1.4 million doses of Daiichi Sankyo's updated COVID-19 vaccine. The purchase is contingent on approval of the shot formulated ...
Nov 16, 2023
Britain taking ‘leisurely’ approach to tackling obesity, say lawmakers
LONDON (Reuters) - Britain's government is taking a "leisurely" approach to tackling unhealthy eating habits and needs to do more to make sure people can get hold of good, affordable food, lawmakers s...
Nov 16, 2023
J&J settles first talc cases to go to trial after failed bankruptcies
By Brendan Pierson (Reuters) - Johnson & Johnson on Thursday said it has settled two lawsuits claiming its talc products caused cancer, the first such cases to go to trial since a federal court reject...
Nov 16, 2023
FDA panel urges Acrotech to speed up study on cancer drugs
(Reuters) - A panel of independent experts to the U.S. health regulator urged Acrotech Biopharma to work with the agency to bring forward the date for releasing trial data that could confirm benefits ...
Nov 16, 2023
US FDA approves AstraZeneca’s breast cancer drug combination
(Reuters) -The U.S. Food and Drug Administration on Thursday approved AstraZeneca's drug capivasertib in combination with an older drug, providing another treatment option for patients with the most c...
Nov 16, 2023
Senior US FDA official Woodcock to retire next year
By Ahmed Aboulenein WASHINGTON (Reuters) -U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as ...
Nov 16, 2023
